The U.S. Food and Drug Administration approved Gilead Sciences' antiviral drug remdesivir for the virus. The intravenous drug has helped shorten the recovery time of some hospitalized Covid-19 patients.
from International: Top News And Analysis https://ift.tt/31yR776
No comments:
Post a Comment
Please do not enter any spam link in the comment box